Loading...

A retrospective pilot evaluation of switching thrombopoietic receptor-agonists in immune thrombocytopenia

Romiplostim and eltrombopag, the first thrombopoietic receptor-agonists with demonstrated efficacy against immune thrombocytopenia in prospective controlled studies, were recently authorized in most countries for adults with chronic immune thrombocytopenia. So far, no data are available about the po...

Full description

Saved in:
Bibliographic Details
Main Authors: Khellaf, Mehdi, Viallard, Jean-François, Hamidou, Mohamed, Cheze, Stéphane, Roudot-Thoraval, Françoise, Lefrere, François, Fain, Olivier, Audia, Sylvain, Abgrall, Jean-François, Michot, Jean-Marie, Dauriac, Charles, Lefort, Sophie, Gyan, Emmanuel, Niault, Mathilde, Durand, Jean-Marc, Languille, Laetitia, Boutboul, David, Bierling, Philippe, Michel, Marc, Godeau, Bertrand
Format: Artigo
Language:Inglês
Published: Ferrata Storti Foundation 2013
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669443/
https://ncbi.nlm.nih.gov/pubmed/23445876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2012.074633
Tags: Add Tag
No Tags, Be the first to tag this record!